Pacific Edge Ltd
NZX:PEB

Watchlist Manager
Pacific Edge Ltd Logo
Pacific Edge Ltd
NZX:PEB
Watchlist
Price: 0.131 NZD
Market Cap: 106.4m NZD

P/E
Price to Earnings

-3.7
Current
-3.8
Median
22.3
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-3.7
=
Market Cap
106.4m NZD
/
Net Income
-28.8m NZD
Market Cap P/E
NZ
Pacific Edge Ltd
NZX:PEB
106.4m NZD -3.7
FR
Pharnext SCA
OTC:PNEXF
6T USD -171 782.3
US
Abbvie Inc
NYSE:ABBV
310.1B USD 73.2
US
Amgen Inc
NASDAQ:AMGN
150.5B USD 36.7
US
Gilead Sciences Inc
NASDAQ:GILD
128.6B USD 266
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.4B USD -226.6
US
Epizyme Inc
F:EPE
94.1B EUR -497.4
AU
CSL Ltd
ASX:CSL
115.1B AUD 25.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61B USD 13.8
US
Seagen Inc
F:SGT
39.3B EUR -57.6
NL
argenx SE
XBRU:ARGX
31.2B EUR 41.1
Earnings Growth PEG
NZ
Pacific Edge Ltd
NZX:PEB
Average P/E: 76.1
Negative Multiple: -3.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -171 782.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
73.2
87%
0.8
US
Amgen Inc
NASDAQ:AMGN
36.7
44%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
266
187%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -226.6 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -497.4 N/A N/A
AU
CSL Ltd
ASX:CSL
25.8
16%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.8
12%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.6 N/A N/A
NL
argenx SE
XBRU:ARGX
41.1
26%
1.6

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-3.6
2-Years Forward
P/E
-5.9
3-Years Forward
P/E
-6.3